Literature DB >> 27799871

Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity.

Mee Sook Park1, Jin Il Kim1, Sehee Park1, Ilseob Lee1, Man-Seong Park1.   

Abstract

The human immune system has evolved to fight against foreign pathogens. It plays a central role in the body's defense mechanism. However, the immune memory geared to fight off a previously recognized pathogen, tends to remember an original form of the pathogen when a variant form subsequently invades. This has been termed 'original antigenic sin'. This adverse immunological effect can alter vaccine effectiveness and sometimes cause enhanced pathogenicity or additional inflammatory responses, according to the type of pathogen and the circumstances of infection. Here we aim to give a simplified conceptual understanding of virus infection and original antigenic sin by comparing and contrasting the two examples of recurring infections such as influenza and dengue viruses in humans.

Entities:  

Keywords:  Dengue; Influenza; Original antigenic sin; Vaccine

Year:  2016        PMID: 27799871      PMCID: PMC5086450          DOI: 10.4110/in.2016.16.5.261

Source DB:  PubMed          Journal:  Immune Netw        ISSN: 1598-2629            Impact factor:   6.303


  62 in total

Review 1.  Immunology of vaccination.

Authors:  P C L Beverley
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

Review 2.  Generation, persistence and plasticity of CD4 T-cell memories.

Authors:  Jason R Lees; Donna L Farber
Journal:  Immunology       Date:  2010-05-10       Impact factor: 7.397

3.  Cell surface recycling of internalized antigen permits dendritic cell priming of B cells.

Authors:  Amy Bergtold; Dharmesh D Desai; Anamika Gavhane; Raphael Clynes
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

4.  Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection.

Authors:  Tao Wu; Yinghong Hu; Young-Tae Lee; Keith R Bouchard; Alexandre Benechet; Kamal Khanna; Linda S Cauley
Journal:  J Leukoc Biol       Date:  2013-09-04       Impact factor: 4.962

Review 5.  Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses.

Authors:  Herman N Eisen
Journal:  Cancer Immunol Res       Date:  2014-05       Impact factor: 11.151

Review 6.  The pathology of influenza virus infections.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

7.  Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.

Authors:  Ana Clara Monsalvo; Juan P Batalle; M Florencia Lopez; Jens C Krause; Jennifer Klemenc; Johanna Zea Hernandez; Bernardo Maskin; Jimena Bugna; Carlos Rubinstein; Leandro Aguilar; Liliana Dalurzo; Romina Libster; Vilma Savy; Elsa Baumeister; Liliana Aguilar; Graciela Cabral; Julia Font; Liliana Solari; Kevin P Weller; Joyce Johnson; Marcela Echavarria; Kathryn M Edwards; James D Chappell; James E Crowe; John V Williams; Guillermina A Melendi; Fernando P Polack
Journal:  Nat Med       Date:  2010-12-05       Impact factor: 53.440

Review 8.  T-cell immunity to infection with dengue virus in humans.

Authors:  Daniela Weiskopf; Alessandro Sette
Journal:  Front Immunol       Date:  2014-03-07       Impact factor: 7.561

Review 9.  Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity.

Authors:  Michael A Schmid; Michael S Diamond; Eva Harris
Journal:  Front Immunol       Date:  2014-12-17       Impact factor: 7.561

10.  Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.

Authors:  F M DAVENPORT; A V HENNESSY; T FRANCIS
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

View more
  11 in total

Review 1.  Towards the Application of Human Defensins as Antivirals.

Authors:  Mee Sook Park; Jin Il Kim; Ilseob Lee; Sehee Park; Joon-Yong Bae; Man-Seong Park
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

2.  Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.

Authors:  Amit Kumar; Claire E P Smith; Elena E Giorgi; Joshua Eudailey; David R Martinez; Karina Yusim; Ayooluwa O Douglas; Lisa Stamper; Erin McGuire; Celia C LaBranche; David C Montefiori; Genevieve G Fouda; Feng Gao; Sallie R Permar
Journal:  PLoS Pathog       Date:  2018-04-19       Impact factor: 6.823

3.  Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Austin Nguyen; Julianne K David; Sean K Maden; Mary A Wood; Benjamin R Weeder; Abhinav Nellore; Reid F Thompson
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

4.  The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains.

Authors:  Mikalai Nienen; Ulrik Stervbo; Felix Mölder; Sviatlana Kaliszczyk; Leon Kuchenbecker; Ludmila Gayova; Brunhilde Schweiger; Karsten Jürchott; Jochen Hecht; Avidan U Neumann; Sven Rahmann; Timm Westhoff; Petra Reinke; Andreas Thiel; Nina Babel
Journal:  Front Immunol       Date:  2019-04-04       Impact factor: 7.561

5.  Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.

Authors:  Jiong Wang; Shannon P Hilchey; Marta DeDiego; Sheldon Perry; Ollivier Hyrien; Aitor Nogales; Jessica Garigen; Fatima Amanat; Nelson Huertas; Florian Krammer; Luis Martinez-Sobrido; David J Topham; John J Treanor; Mark Y Sangster; Martin S Zand
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

6.  Dynamics of Influenza A (H5N1) virus protein sequence diversity.

Authors:  Hadia Syahirah Abd Raman; Swan Tan; Joseph Thomas August; Asif M Khan
Journal:  PeerJ       Date:  2020-05-27       Impact factor: 2.984

7.  Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination.

Authors:  Victoria Bradt; Stefan Malafa; Amrei von Braun; Johanna Jarmer; Georgios Tsouchnikas; Iris Medits; Kerstin Wanke; Urs Karrer; Karin Stiasny; Franz X Heinz
Journal:  NPJ Vaccines       Date:  2019-09-06       Impact factor: 7.344

Review 8.  Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.

Authors:  Katie L Flanagan; Emma Best; Nigel W Crawford; Michelle Giles; Archana Koirala; Kristine Macartney; Fiona Russell; Benjamin W Teh; Sophie Ch Wen
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

Review 9.  The Immune Correlates of Orthohantavirus Vaccine.

Authors:  Joon-Yong Bae; Jin Il Kim; Mee Sook Park; Gee Eun Lee; Heedo Park; Ki-Joon Song; Man-Seong Park
Journal:  Vaccines (Basel)       Date:  2021-05-18

10.  SARS-CoV-2 vaccination in the context of original antigenic sin.

Authors:  Marek Petráš; Ivana Králová Lesná
Journal:  Hum Vaccin Immunother       Date:  2021-07-09       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.